Lobular Capillary Hemangioma: An Immunohistochemical Study Including Steroid Hormone Receptor Status

1992 ◽  
Vol 97 (6) ◽  
pp. 770-775 ◽  
Author(s):  
Guy E. Nichols ◽  
Michael J. Gaffey ◽  
Stacey E. Mills ◽  
Lawrence M. Weiss
Keyword(s):  
Hormone Receptor ◽  
Immunohistochemical Study ◽  
Steroid Hormone ◽  
Capillary Hemangioma ◽  
Hormone Receptor Status ◽  
Steroid Hormone Receptor ◽  
Lobular Capillary Hemangioma ◽  
Receptor Status

Efficacy of sequential cyclical hormonal therapy in endometrial cancer and its correlation with steroid hormone receptor status

1988 ◽  
Vol 31 (2) ◽  
pp. 327-337 ◽  
Author(s):  
J. Ayoub ◽  
P. Audet-Lapointe ◽  
Y. Méthot ◽  
J. Hanley ◽  
R. Beaulieu ◽  
...  
Keyword(s):  
Endometrial Cancer ◽  
Hormonal Therapy ◽  
Hormone Receptor ◽  
Steroid Hormone ◽  
Hormone Receptor Status ◽  
Steroid Hormone Receptor ◽  
Receptor Status

Breast cancer outcomes by steroid hormone receptor status assessed visually and by computer image analysis

2012 ◽  
Vol 61 (2) ◽  
pp. 283-292 ◽  
Author(s):  
Zahra M A Mohammed ◽  
Joanne Edwards ◽  
Clare Orange ◽  
Elizabeth Mallon ◽  
Julie C Doughty ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Image Analysis ◽  
Hormone Receptor ◽  
Computer Image ◽  
Steroid Hormone ◽  
Hormone Receptor Status ◽  
Steroid Hormone Receptor ◽  
Computer Image Analysis ◽  
Receptor Status ◽  
Breast Cancer Outcomes

Prognostic significance of cathepsins B and L in primary human breast cancer.

1998 ◽  
Vol 16 (3) ◽  
pp. 1013-1021 ◽  
Author(s):  
J A Foekens ◽  
J Kos ◽  
H A Peters ◽  
M Krasovec ◽  
M P Look ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Prognostic Factors ◽  
Lymph Nodes ◽  
Hormone Receptor ◽  
Steroid Hormone ◽  
Menopausal Status ◽  
Hormone Receptor Status ◽  
Steroid Hormone Receptor ◽  
Receptor Status ◽  
Positive Lymph Nodes

PURPOSE Evaluation of the clinical significance of cytosolic tumor levels of the lysosomal cysteine proteases cathepsin B (catB) and cathepsin L (catL) in patients with primary breast cancer. PATIENTS AND METHODS CatB (n = 1,500) and catL (n = 1,391) levels were determined by enzyme-linked immunosorbent assay (ELISA) in cytosols routinely prepared from frozen-tissue samples that were submitted to our laboratory for the assessment of steroid-hormone-receptor status. The median duration of follow-up of patients still alive at the time of analysis was 93 months. RESULTS Relating catB and catL levels with classical prognostic factors, the proteases were positively correlated with the number of positive lymph nodes (P < .01), and negatively with the level of steroid-hormone receptors (P < .01). We did not find a significant relationship between catB or catL levels with age and menopausal status of the patients or with the size of the primary tumor. The levels of catB and catL were positively correlated with each other and with the rates of relapse and death (all, P < .0001). In multivariate regression analysis for relapse-free survival (RFS) and overall survival (OS), corrected for the contribution of age/menopausal status, tumor size, the number of positive lymph nodes, and steroid-hormone-receptor status, catB and catL were significant predictors of the rates of relapse and death (all, P < .01). No statistically significant interactions of catB or catL with any of the classical prognostic factors or with each other were observed in their associations with the rates of relapse and death. CONCLUSION CatB and catL levels measured in routinely prepared cytosols are strong parameters to predict the rate of relapse and the length of survival after treatment of the primary breast tumor.

pS2 in Breast Carcinoma: Association with Steroid Hormone Receptor Status

1998 ◽  
Vol 84 (6) ◽  
pp. 691-694 ◽  
Author(s):  
Dragica Nikolić-Vukosavljević ◽  
Gordana Grujić-Adanja ◽  
Radmila Janković ◽  
Mirjana Branković-Magić ◽  
Đoka Polić ◽  
...  
Keyword(s):  
Breast Carcinoma ◽  
Hormone Receptor ◽  
Steroid Hormone ◽  
Hormone Receptor Status ◽  
Steroid Hormone Receptor ◽  
Receptor Status
Sign in / Sign up

Export Citation Format

Share Document